Barkun AN - Search Results

1

Editorial: how can we best promote the routine use of scores that are accurate at predicting outcomes in patients with upper gastrointestinal bleeding?

Bardou M, Barkun AN. Bardou M, et al. Among authors: barkun an. Aliment Pharmacol Ther. 2020 Jan;51(2):305-306. doi: 10.1111/apt.15574. Aliment Pharmacol Ther. 2020. PMID: 31880013 No abstract available.

2

Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.

Barkun AN, Cockeram AW, Plourde V, Fedorak RN. Barkun AN, et al. Aliment Pharmacol Ther. 1999 Dec;13(12):1565-84. doi: 10.1046/j.1365-2036.1999.00623.x. Aliment Pharmacol Ther. 1999. PMID: 10594391 Free article. Review.

3

Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.

Makris N, Crott R, Fallone CA, Bardou M, Barkun A. Makris N, et al. Gastrointest Endosc. 2003 Jul;58(1):14-22. doi: 10.1067/mge.2003.295. Gastrointest Endosc. 2003. PMID: 12838214

4

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.

Rahme E, Barkun AN, Toubouti Y, Bardou M. Rahme E, et al. Among authors: barkun an. Gastroenterology. 2003 Aug;125(2):404-12. doi: 10.1016/s0016-5085(03)00880-1. Gastroenterology. 2003. PMID: 12891542

5

Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease.

Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Romagnuolo J, et al. Among authors: barkun an. Ann Intern Med. 2003 Oct 7;139(7):547-57. doi: 10.7326/0003-4819-139-7-200310070-00006. Ann Intern Med. 2003. PMID: 14530225

6

Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.

Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Barkun A, et al. Ann Intern Med. 2003 Nov 18;139(10):843-57. doi: 10.7326/0003-4819-139-10-200311180-00012. Ann Intern Med. 2003. PMID: 14623622 Free article.

7

High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.

Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. Barkun AN, et al. Aliment Pharmacol Ther. 2004 Mar 1;19(5):591-600. doi: 10.1046/j.1365-2036.2004.01808.x. Aliment Pharmacol Ther. 2004. PMID: 14987328 Free article.

8

The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.

Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. Barkun AN, et al. Aliment Pharmacol Ther. 2004 Jul 15;20(2):195-202. doi: 10.1111/j.1365-2036.2004.02035.x. Aliment Pharmacol Ther. 2004. PMID: 15233700 Free article. Review.

9

Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.

Rahme E, Barkun AN, Adam V, Bardou M. Rahme E, et al. Among authors: barkun an. Drug Saf. 2004;27(13):1019-42. doi: 10.2165/00002018-200427130-00004. Drug Saf. 2004. PMID: 15471508 Review.

10

Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence.

Bardou M, Barkun AN, Ghosn J, Hudson M, Rahme E. Bardou M, et al. Among authors: barkun an. Clin Gastroenterol Hepatol. 2004 Oct;2(10):880-7. doi: 10.1016/s1542-3565(04)00389-1. Clin Gastroenterol Hepatol. 2004. PMID: 15476151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

488 results

Search Page

Filters